Federated Hermes
AVIR icon

Federated Hermes’s Atea Pharmaceuticals AVIR Stock Holding History

Federated Hermes’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$769 Sell
143
-1,159
-89% -$5.32K ﹤0.01% 2016
2025
Q4 		$4.65K Sell
1,302
-2,140
-62% -$6.8K ﹤0.01% 1899
2025
Q3 		$9.98K Hold
3,442
– – ﹤0.01% 1879
2025
Q2 		$12.4K Sell
3,442
-579,287
-99% -$1.73M ﹤0.01% 1788
2025
Q1 		$1.74M Sell
582,729
-210
-0% -$655 ﹤0.01% 972
2024
Q4 		$1.95M Buy
582,939
+10,856
+2% +$36.1K ﹤0.01% 940
2024
Q3 		$1.92M Buy
572,083
+815
+0.1% +$2.96K ﹤0.01% 944
2024
Q2 		$1.89M Sell
571,268
-91
-0% -$339 ﹤0.01% 936
2024
Q1 		$2.31M Sell
571,359
-24,333
-4% -$95.2K 0.01% 896
2023
Q4 		$1.82M Sell
595,692
-13,094
-2% -$39.7K ﹤0.01% 975
2023
Q3 		$1.83M Sell
608,786
-5,204
-0.8% -$17.7K ﹤0.01% 951
2023
Q2 		$2.3M Sell
613,990
-1,425,066
-70% -$5.34M 0.01% 908
2023
Q1 		$6.83M Sell
2,039,056
-1,041,841
-34% -$4.23M 0.02% 633
2022
Q4 		$14.8M Sell
3,080,897
-545,921
-15% -$2.76M 0.04% 448
2022
Q3 		$20.6M Buy
3,626,818
+38,687
+1% +$296K 0.06% 374
2022
Q2 		$25.5M Buy
3,588,131
+1,536,799
+75% +$10.5M 0.07% 332
2022
Q1 		$14.8M Buy
+2,051,332
New +$13.9M 0.03% 514

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federated Hermes's AVIR Position: Q1 2026 in Review

Federated Hermes reduced its Atea Pharmaceuticals (AVIR) stake by 89% in Q1 2026, selling an estimated $5.32K and leaving 143 shares worth $769. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Federated Hermes first reported a position in AVIR in Q1 2022 and has held it in 17 quarters since. The position peaked at $25.5M in Q2 2022. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Federated Hermes held 143 shares of Atea Pharmaceuticals worth $769 as of Q1 2026.
  • Federated Hermes sold 1,159 Atea Pharmaceuticals shares in Q1 2026, an estimated $5.32K.
  • Atea Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #2016 holding.
  • Federated Hermes first reported a position in Atea Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Federated Hermes's Atea Pharmaceuticals position peaked at $25.5M in Q2 2022.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.